Sante Capital Fund’s Target TGT Stock Holding History

Sante Capital Fund’s Portfolio TGT Stock Details TGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,170	Closed	-$885K	–	76
2022 Q1	$885K	Buy	+4,170	New	+$902K	0.99%	39

Other funds holding TGT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sante Capital Fund's TGT Position: Q2 2022 in Review

Sante Capital Fund sold out of Target (TGT) in Q2 2022, closing a stake of 4,170 shares — an estimated $885K sold.

Sante Capital Fund first reported a position in TGT in Q1 2022 and held it in 1 quarter. The position peaked at $885K in Q1 2022. 1,931 funds tracked by Wall St. Rank hold TGT as of Q2 2022.

Sante Capital Fund reported no remaining Target position as of Q2 2022 after selling out during the quarter.
Sante Capital Fund sold 4,170 Target shares in Q2 2022, an estimated $885K.
Sante Capital Fund first reported a position in Target in Q1 2022 and held it in 1 quarter.
Sante Capital Fund's Target position peaked at $885K in Q1 2022.
1,931 funds tracked by Wall St. Rank held Target as of Q2 2022.

Based on Sante Capital Fund's 13F filing for Q2 2022, filed 27 Jul 2022.